40 Stocks Moving In Friday's Mid-Day Session

Author: Lisa Levin | January 10, 2020 01:29pm

Gainers

CounterPath, Corp. (NASDAQ:CPAH) shares climbed 126.8% to $2.20 after the company partnered with Honeywell to create unified communications solution for mobile devices and handheld scanners.
Sorrento Therapeutics Inc (NASDAQ:SRNE) gained 35.8% to $4.63 following news it received an unsolicited acquisition offer from private equity at $7 per share.
PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) shares gained 28.5% to $7.26 after the company announced a financing and co-development collaboration with SFJ Pharmaceuticals for PB2452. PhaseBio to receive $120 million in development funding.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares rose 28.3% to $56.09 after the company announced positive topline cohort 3 results and improved longer-term Cohort 2 results from the Phase 1/2 study of DTX301 gene therapy.
Polymet Mining Corp (NYSE:PLM) jumped 20.2% to $0.4798 after the Minnesota Pollution Control Agency defended air permits it gave to the company, which is trying to open a copper-nickel mine in the state.
ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) gained 17.2% to $2.38.
Trillium Therapeutics Inc. (NASDAQ:TRIL) rose 14.8% to $3.32 after surging 93.96% on Thursday.
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) shares rose 13.3% to $2.1066 after the company announced positive results from ATI-450-PKPD-101.
SYNNEX Corporation (NYSE:SNX) rose 13.1% to $145.66 after the company reported upbeat results for its fourth quarter and announced plans to separate into two publicly traded companies. The company also issued Q1 earnings guidance above analyst estimates.
NanoViricides, Inc. (NYSE:NNVC) shares gained 13.1% to $3.7195.
Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) rose 12.8% to $4.23.
Revance Therapeutics, Inc. (NASDAQ:RVNC) gained 10.9% to $18.27 after the company signed US distribution agreement with TEOXANE SA.
Soleno Therapeutics, Inc. (NASDAQ:SLNO) jumped 10.5% to $3.15.
Moderna, Inc. (NASDAQ:MRNA) rose 10.4% to $20.32 after the company announced positive data from the Phase 1 study of its cytomegalovirus vaccine.
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) gained 10.4% to $2.9375.
Nektar Therapeutics (NASDAQ:NKTR) gained 9.7% to $23.68 after the company and Bristol-Myers agreed to a new joint development plan to advance bempeg plus nivolumab into multiple new registrational trials.
Simulations Plus, Inc. (NASDAQ:SLP) rose 5.8% to $33.51 following strong Q1 results.
Beyond Meat, Inc. (NASDAQ:BYND) rose 5.7% to $95.41 after climbing 10.76% on Thursday.
Dermira Inc (NASDAQ:DERM) shares rose 5.4% to $19.33 after Eli Lilly And Co (NYSE:LLY) reported a deal to buy the company for $18.75 per share in cash.
T2 Biosystems Inc (NASDAQ:TTOO) rose 5.3% to $1.20 after the company issued preliminary Q4 sales guidance of roughly $3 million and product revenue of roughly $1.5 million.
Infosys Limited (NYSE:INFY) shares rose 4.4% to $10.94 after reporting upbeat quarterly profit.

Check out these big penny stock gainers and losers

Losers

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) shares dipped 44% to $13.86 after the company reported preliminary FY19 Andexxa global net revenues of $111 million.
RumbleON Inc (NASDAQ:RMBL) fell 26.1% to $0.5996 after the company issued Q4 and FY19 sales guidance below analyst estimates, and reported a common stock offering of no disclosed size.
Six Flags Entertainment Corporation (NYSE:SIX) fell 18.5% to $35.67 after the company disclosed that development of co-branded parks in China has encountered continued challenges. Wells Fargo downgraded the stock from Overweight to Equal-Weight and lowered the price target from $49 to $42 per share.
Cryoport, Inc. (NASDAQ:CYRX) fell 17.2% to $15.03. Cryoport sees preliminary Q4 sales of $9.2 million.
Sportsman's Warehouse Holdings Inc (NASDAQ:SPWH) fell 15.4% to $6.76 after the company lowered its guidance for FY19. The company also issued weak forecast for the fourth quarter.
Camber Energy, Inc. (NYSE:CEI) dropped 14.7% to $2.3108.
Turning Point Therapeutics, Inc. (NASDAQ:TPTX) dipped 12.6% to $57.12. Turning Point Therapeutics said Jean Cui will step down as chief scientific officer Jan. 31, with family reasons cited for the departure. Cui, however, will serve as a consultant and support the company during a transition period until June 30.
Aptinyx Inc (NASDAQ:APTX) fell 10.3% to $3.23. Aptinyx priced its 10.17 million share common stock offering at $3 per share.
Inpixon (NASDAQ:INPX) fell 9.9% to $4.64 after falling 6.02% on Thursday.
Chembio Diagnostics, Inc. (NASDAQ:CEMI) dropped 9.5% to $4.40 after the company reported the resignation of President and CEO John Sperzel.
Applied Genetic Technologies Corporation (NASDAQ:AGTC) fell 9.3% to $8.41 after rising 122.84% on Thursday.
Genetic Technologies Limited (NASDAQ:GENE) dipped 9.3% to $4.29.
Kimbell Royalty Partners, LP (NYSE:KRP) fell 8.7% to $15.86 after the company reported a 5 million common unit offering. Kimbell Royalty Partners also reported a $175 million acquisition of mineral and royalty interests in a cash and unit transaction.
Grubhub Inc. (NYSE:GRUB) fell 8.1% to $51.22. Grubhub said It 'unequivocally' isn't running a sale process, Bloomberg reported.
VOXX International Corp (NASDAQ:VOXX) fell 7.7% to $4.42 after the company reported Q3 EPS results down from last year and worse-than-expected sales results.
Pier 1 Imports, Inc. (NYSE:PIR) dropped 7% to $3.50.
Urban Outfitters, Inc. (NASDAQ:URBN) fell 5.5% to $26.16 after the company reported there will be greater pressure on Q4 gross profit margin than originally expected. Wholesale segment net sales decreased 9% and the company spent more than anticipated on delivery, for the 2 months ended December 31, 2019.
Aehr Test Systems (NASDAQ:AEHR) fell 5.5% to $2.0220 after the company reported Q2 results.
KB Home (NYSE:KBH) fell 4% to $35.62 after the company reported worse-than-expected Q4 sales results.